Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional outcomes of single-session holmium laser enucleation of the prostate and high-intensity focused ultrasound in management of patients with prostate cancer and enlarged prostate: results from a pilot study.
Delgado J, Porto JG, Bhatia A, Raymo A, Blachman-Braun R, Ajami T, Rathinam A, Freitas PFS, Khandekar A, Marcovich R, Parekh DJ, Nahar B, Shah HN. Delgado J, et al. Among authors: nahar b. World J Urol. 2024 Dec 30;43(1):53. doi: 10.1007/s00345-024-05424-0. World J Urol. 2024. PMID: 39739024 Free PMC article.
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.
Kimbel IM, Wallaengen V, Zacharaki EI, Breto AL, Algohary A, Carbohn S, Gaston SM, Soodana-Prakash N, Freitas PFS, Kryvenko ON, Castillo P, Abramowitz MC, Ritch CR, Nahar B, Gonzalgo ML, Parekh DJ, Pollack A, Punnen S, Stoyanova R. Kimbel IM, et al. Among authors: nahar b. Acad Radiol. 2024 Dec 17:S1076-6332(24)00853-5. doi: 10.1016/j.acra.2024.11.008. Online ahead of print. Acad Radiol. 2024. PMID: 39694787
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial.
Ajami T, Yu H, Porto JG, Prakash NS, Williams A, Avda Y, Malpani A, Mendiola DF, Freitas PFS, Khandekar A, Swain S, Gaston S, Mahal B, Cortizas E, Szczotka Z, Gerard T, Kava B, Stoyanova R, Kryvenko ON, Castillo P, Ritch CR, Nahar B, Gonzalgo ML, Pollack A, Parekh DJ, Punnen S. Ajami T, et al. Among authors: nahar b. Eur Urol Focus. 2024 Dec 10:S2405-4569(24)00256-6. doi: 10.1016/j.euf.2024.11.012. Online ahead of print. Eur Urol Focus. 2024. PMID: 39665894
Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned.
Nahar B, Ajami T, Williams A, Soodana Prakash N, Khandekar A, Freitas PFS, Malpani A, Rayan J, Sureshkumar K, Ritch CR, Gonzalgo ML, Punnen S, Parekh DJ. Nahar B, et al. Eur Urol Focus. 2024 Nov 29:S2405-4569(24)00246-3. doi: 10.1016/j.euf.2024.11.005. Online ahead of print. Eur Urol Focus. 2024. PMID: 39613544
Changing times: trends in risk classification, tumor upstaging, and positive surgical margins after radical prostatectomy - results from a contemporary National Cancer Database study.
Freitas PFS, Blachman-Braun R, Soodana-Prakash N, Williams AD, Ritch CR, Punnen S, Gonzalgo ML, Parekh D, Nahar B. Freitas PFS, et al. Among authors: nahar b. World J Urol. 2024 Sep 30;42(1):551. doi: 10.1007/s00345-024-05262-0. World J Urol. 2024. PMID: 39347950 Free PMC article.
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score.
Hougen HY, Reis IM, Han S, Prakash NS, Thomas J, Stoyanova R, Castillo RP, Kryvenko ON, Ritch CR, Nahar B, Gonzalgo ML, Gaston SM, Abramowitz MC, Dal Pra A, Mahal BA, Pollack A, Parekh DJ, Punnen S. Hougen HY, et al. Among authors: nahar b. Prostate Cancer Prostatic Dis. 2024 Sep 27. doi: 10.1038/s41391-024-00898-w. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39333697
Assessing safety and efficacy of a novel glucose-free amino acid oral rehydration solution for watery diarrhea management in children: a randomized, controlled, phase III trial.
Bardhan PK, Das R, Nahar B, Haque MA, Sobi RA, Sultana AA, Mahfuz M, Fawkes N, Smith AB, Vidyasagar S, Fontaine O, Ahmed T. Bardhan PK, et al. Among authors: nahar b. EClinicalMedicine. 2024 May 17;72:102630. doi: 10.1016/j.eclinm.2024.102630. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38800804 Free PMC article.
103 results